Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Bacterial Infections and Mycoses

  Free Subscription

Articles published in Dig Dis Sci

Retrieve available abstracts of 47 articles:
HTML format

Single Articles

    December 2021
  1. LASZKOWSKA M, Kim J, Faye AS, Joelson AM, et al
    Prevalence of Clostridioides difficile and Other Gastrointestinal Pathogens in Patients with COVID-19.
    Dig Dis Sci. 2021;66:4398-4405.
    PubMed     Abstract available

    November 2021
  2. BAIU I, Forgo E, Kin C, Weiser TG, et al
    Cec and You Shall Find: Cecal Perforation in a Patient with COVID-19.
    Dig Dis Sci. 2021;66:3731-3734.

    October 2021
  3. SPRAGUE R, Warny K, Pollock N, Daugherty K, et al
    Absence of Toxemia in Clostridioides difficile Infection: Results from Ultrasensitive Toxin Assay of Serum.
    Dig Dis Sci. 2021;66:3303-3306.
    PubMed     Abstract available

    September 2021
  4. HSU D, Martin B, Forgo E, Greene E, et al
    Tough to Swallow: Dysphagia in a Child with an Aberrant Left Subclavian Artery.
    Dig Dis Sci. 2021;66:2882-2887.

  5. VARMA S, Faye AS, Kannan A, Lawlor G, et al
    Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD.
    Dig Dis Sci. 2021;66:3113-3123.
    PubMed     Abstract available

    July 2021
  6. HESKETT CW, Teafatiller T, Hennessey C, Gareau MG, et al
    Enteropathogenic Escherichia coli Infection Inhibits Intestinal Ascorbic Acid Uptake via Dysregulation of Its Transporter Expression.
    Dig Dis Sci. 2021;66:2250-2260.
    PubMed     Abstract available

    June 2021
  7. SHAH ED
    Breath Test or Duodenal Aspirate for Small Intestinal Bacterial Overgrowth: Still No Breath of Fresh Air.
    Dig Dis Sci. 2021;66:1770-1771.

  8. CANGEMI DJ, Lacy BE, Wise J
    Diagnosing Small Intestinal Bacterial Overgrowth: A Comparison of Lactulose Breath Tests to Small Bowel Aspirates.
    Dig Dis Sci. 2021;66:2042-2050.
    PubMed     Abstract available

  9. AGARWAL A, Maheshwari A, Verma S, Arrup D, et al
    Superiority of Higher-Volume Fresh Feces Compared to Lower-Volume Frozen Feces in Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Colitis.
    Dig Dis Sci. 2021;66:2000-2004.
    PubMed     Abstract available

    May 2021
  10. CHEN J, Hubbard A, Bagley L, Shiau R, et al
    Prevalence of Latent Tuberculosis Infection Among Persons with Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2021 May 30. pii: 10.1007/s10620-021-07056.
    PubMed     Abstract available

  11. TURNER KO, Genta RM, Sonnenberg A
    The Meaning of Incidental Goblet Cells at the Gastroesophageal Junction.
    Dig Dis Sci. 2021;66:1588-1592.
    PubMed     Abstract available

  12. SINGH AK, Kumar R, Gupta P, Kumar-M P, et al
    FDG-PET-CT Enterography Helps Determine Clinical Significance of Suspected Ileocecal Thickening: A Prospective Study.
    Dig Dis Sci. 2021;66:1620-1630.
    PubMed     Abstract available

    March 2021
  13. MA C, MacDonald JK, Nguyen TM, Vande Casteele N, et al
    Pharmacological Interventions for the Prevention and Treatment of Immune Checkpoint Inhibitor-Associated Enterocolitis: A Systematic Review.
    Dig Dis Sci. 2021 Mar 26. pii: 10.1007/s10620-021-06948.
    PubMed     Abstract available

    February 2021
  14. CAMILLERI M, Szarka LA
    Every Breath Test You Take: Practical Advice on Breath Testing Used to Detect Small Intestinal Bacterial Overgrowth.
    Dig Dis Sci. 2021;66:331-333.

  15. AGRAWAL G, Aitken J, Hamblin H, Collins M, et al
    Putting Crohn's on the MAP: Five Common Questions on the Contribution of Mycobacterium avium subspecies paratuberculosis to the Pathophysiology of Crohn's Disease.
    Dig Dis Sci. 2021;66:348-358.
    PubMed     Abstract available

  16. RAMAI D, Zakhia K, Fields PJ, Ofosu A, et al
    Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2021;66:369-380.
    PubMed     Abstract available

    January 2021
  17. LU L, Xu W, Liu J, Chen L, et al
    DRG1 Maintains Intestinal Epithelial Cell Junctions and Barrier Function by Regulating RAC1 Activity in Necrotizing Enterocolitis.
    Dig Dis Sci. 2021 Jan 20. pii: 10.1007/s10620-020-06812.
    PubMed     Abstract available

    FMT for Severe C. difficile Infection: If at First You Do No Harm, the Second Time's a Charm.
    Dig Dis Sci. 2021;66:5-6.

  19. ALLEGRETTI JR, Mehta SR, Kassam Z, Kelly CR, et al
    Risk Factors that Predict the Failure of Multiple Fecal Microbiota Transplantations for Clostridioides difficile Infection.
    Dig Dis Sci. 2021;66:213-217.
    PubMed     Abstract available

  20. KIM D, Yoo ER, Li AA, Tighe SP, et al
    Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014.
    Dig Dis Sci. 2021;66:296-307.
    PubMed     Abstract available

  21. BERINSTEIN JA, Steiner CA, Roth KJ, Briggs E, et al
    Association of Household Pets, Common Dietary Factors, and Lifestyle Factors with Clostridium difficile Infection.
    Dig Dis Sci. 2021;66:206-212.
    PubMed     Abstract available

    December 2020
    Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults: Treat Early, Treat Often.
    Dig Dis Sci. 2020;65:3425-3427.

  23. HUANG A, Lee K, Chan M, Mak K, et al
    Getting the OK to Import Zero K MVI: Maintaining TTR in an Infant with SBS.
    Dig Dis Sci. 2020;65:3486-3492.

  24. LUO Y, Tixier EN, Grinspan AM
    Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Dig Dis Sci. 2020;65:3647-3651.
    PubMed     Abstract available

    November 2020
  25. SINGH M, Singh V, Schurman JV, Friesen CA, et al
    Mucosal Th17 Cells Are Increased in Pediatric Functional Dyspepsia Associated with Chronic Gastritis.
    Dig Dis Sci. 2020;65:3184-3190.
    PubMed     Abstract available

    October 2020
  26. HOURI H, Yadegar A, Zali MR
    How Infection with C. difficile Infection Aggravates Inflammatory Bowel Disease: Is It CDI or the CDAI?
    Dig Dis Sci. 2020 Oct 23. pii: 10.1007/s10620-020-06667.

    September 2020
  27. SMITH R, Hubers J, Farraye FA, Sampene E, et al
    Accuracy of Self-Reported Vaccination Status in a Cohort of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Sep 29. pii: 10.1007/s10620-020-06631.
    PubMed     Abstract available

    August 2020
  28. MOKTAN V, Jonica E, Li Z, Hata DJ, et al
    C. difficile and the Patient with Inflammatory Bowel Disease: A Testing Dilemma.
    Dig Dis Sci. 2020 Aug 16. pii: 10.1007/s10620-020-06496.

  29. LAM AY, Gutin LS, Nguyen Y, Velayos FS, et al
    Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2020 Aug 4. pii: 10.1007/s10620-020-06521.

    July 2020
  30. KUMAR A, Teslova T, Taub E, Miller JD, et al
    Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications.
    Dig Dis Sci. 2020 Jul 2. pii: 10.1007/s10620-020-06439.
    PubMed     Abstract available

  31. MATYSIAK-BUDNIK T, Camargo MC, Piazuelo MB, Leja M, et al
    Recent Guidelines on the Management of Patients with Gastric Atrophy: Common Points and Controversies.
    Dig Dis Sci. 2020;65:1899-1903.
    PubMed     Abstract available

    June 2020
  32. ZHORNITSKIY A, Nguyen A, Kaunitz J
    Impacting Underserved Communities as a GI Trainee.
    Dig Dis Sci. 2020;65:1596-1598.
    PubMed     Abstract available

    May 2020
  33. FERRARESE A, Burra P, Senzolo M
    A Commentary on the Interplay Between Severity of Liver Disease and Bacterial Infection in Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2020 May 8. pii: 10.1007/s10620-020-06278.

    Mixed Bag: How C. Difficile Can Cause Pouchitis.
    Dig Dis Sci. 2020;65:1291-1292.

  35. GOSAI F, Covut F, Alomari M, Hitawala A, et al
    Obesity Is Associated with Decreased Risk of Clostridium difficile Infection in Hospitalized Patients with Pouchitis.
    Dig Dis Sci. 2020;65:1423-1428.
    PubMed     Abstract available

    April 2020
  36. KOUITCHEU MABEKU LB, Bello Epesse M, Fotsing S, Kamgang R, et al
    Stool Antigen Testing, a Reliable Noninvasive Method of Assessment of Helicobacter pylori Infection Among Patients with Gastro-duodenal Disorders in Cameroon.
    Dig Dis Sci. 2020 Apr 30. pii: 10.1007/s10620-020-06219.
    PubMed     Abstract available

    March 2020
  37. GUPTA A, Wash C, Wu Y, Sorrentino D, et al
    Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 23. pii: 10.1007/s10620-020-06205.
    PubMed     Abstract available

  38. GUEVARA B, Cogdill AG
    Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
    Dig Dis Sci. 2020 Mar 13. pii: 10.1007/s10620-020-06193.
    PubMed     Abstract available

  39. JANSSON-KNODELL CL, Harris CE, Loftus EV Jr, Walker RC, et al
    Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06181.
    PubMed     Abstract available

    February 2020
  40. LUO L, Ji Y, Yu L, Huang Y, et al
    14-Day High-Dose Amoxicillin- and Metronidazole-Containing Triple Therapy With or Without Bismuth as First-Line Helicobacter pylori Treatment.
    Dig Dis Sci. 2020 Feb 4. pii: 10.1007/s10620-020-06115.
    PubMed     Abstract available

    January 2020
  41. LIMSRIVILAI J, Saleh ZM, Johnson LA, Stidham RW, et al
    Prevalence and Effect of Intestinal Infections Detected by a PCR-Based Stool Test in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 24. pii: 10.1007/s10620-020-06071.
    PubMed     Abstract available

  42. NAM SY, Lee SW, Jeon SW, Kwon YH, et al
    Helicobacter pylori Eradication Regressed Gastric Hyperplastic Polyp: A Randomized Controlled Trial.
    Dig Dis Sci. 2020 Jan 23. pii: 10.1007/s10620-020-06065.
    PubMed     Abstract available

    November 2019
  43. NGUYEN TH, Mallepally N, Hammad T, Liu Y, et al
    Prevalence of Helicobacter pylori Positive Non-cardia Gastric Adenocarcinoma Is Low and Decreasing in a US Population.
    Dig Dis Sci. 2019 Nov 14. pii: 10.1007/s10620-019-05955.
    PubMed     Abstract available

  44. TIAN H, Chen L, Wu X, Li F, et al
    Infectious Complications in Severe Acute Pancreatitis: Pathogens, Drug Resistance, and Status of Nosocomial Infection in a University-Affiliated Teaching Hospital.
    Dig Dis Sci. 2019 Nov 5. pii: 10.1007/s10620-019-05924.
    PubMed     Abstract available

    October 2019
  45. HAN Y, Yan T, Ma H, Yao X, et al
    Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model.
    Dig Dis Sci. 2019 Oct 30. pii: 10.1007/s10620-019-05910.
    PubMed     Abstract available

  46. ALLEGRETTI JR, Marcus J, Storm M, Sitko J, et al
    Clinical Predictors of Recurrence After Primary Clostridioides difficile Infection: A Prospective Cohort Study.
    Dig Dis Sci. 2019 Oct 30. pii: 10.1007/s10620-019-05900.
    PubMed     Abstract available

  47. LEJA M, Dumpis U
    What Would the Screen-and-Treat Strategy for Helicobacter pylori Mean in Terms of Antibiotic Consumption?
    Dig Dis Sci. 2019 Oct 28. pii: 10.1007/s10620-019-05893.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.